Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection

Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection

ABSTRACT With much of the world infected with or vaccinated against severe acute respiratory syndrome coronavirus 2 (commonly abbreviated SARS-CoV-2; abbreviated here SARS2), understanding the immune responses to the SARS2 spike (S) protein in different situations is crucial to controlling the pande...

Full description

Bibliographic Details
Main Authors: Mohammad M. Sajadi, Amber Myers, James Logue, Saman Saadat, Narjes Shokatpour, James Quinn, Michelle Newman, Meagan Deming, Zahra Rikhtegaran Tehrani, Laurence S. Magder, Maryam Karimi, Abdolrahim Abbasi, Mike Shlyak, Lauren Baracco, Matthew B. Frieman, Shane Crotty, Anthony D. Harris
Format: Article
Language:English
Published: American Society for Microbiology 2022-12-01
Series:mSphere
Subjects:
SARS-CoV-2
vaccination
systemic response
mucosal immunity
IgA
IgG
Online Access:https://journals.asm.org/doi/10.1128/msphere.00279-22

Internet

https://journals.asm.org/doi/10.1128/msphere.00279-22

Similar Items